Maillot C, Million M, Wei J Y, Gauthier A, Taché Y
CURE: Digestive Diseases Research Center, VA Greater Los Angeles Healthcare System, Los Angeles, California 90073, USA.
Gastroenterology. 2000 Dec;119(6):1569-79. doi: 10.1053/gast.2000.20251.
BACKGROUND & AIMS: Corticotropin-releasing factor (CRF) exerts its action through CRF receptors 1 and 2 (CRF-R1 and CRF-R2). CRF has preferential affinity for CRF-R1, whereas urocortin displays high affinity for both. We investigated changes in colonic motor function after intraperitoneal (IP) injection of CRF-related peptides.
Colonic motility was recorded in vivo in conscious rats equipped with electrodes chronically implanted in the cecum and proximal colon or in vitro in distal colon; fecal output was monitored in naive rats.
Rat CRF, rat urocortin, and amphibian sauvagine (10 microg/kg, IP) induced a new pattern of cecocolonic myoelectric activity characterized by clustered spike bursts of long duration; the percentage of occurrence was highest after CRF. The rank order of potency to increase fecal pellet output after IP peptide injection (0.3-10 microg/kg, IP) was CRF > urocortin = sauvagine. The CRF-R1/R2 antagonist astressin (33 microg/kg, IP) and the CRF-R1 antagonist CP-154,526 (20 mg/kg, subcutaneously) inhibited IP CRF-induced changes in cecocolonic myoelectric activity and IP CRF- and water avoidance stress-induced fecal output. In vitro, CRF injected into the inferior mesenteric artery increased distal colonic myoelectric activity compared with saline injection.
These results demonstrate that CRF acts peripherally to stimulate colonic motility and that CRF-R1 is primarily involved in mediating IP CRF/urocortin- and water avoidance stress-induced colonic motor response.
促肾上腺皮质激素释放因子(CRF)通过CRF受体1和2(CRF-R1和CRF-R2)发挥作用。CRF对CRF-R1具有优先亲和力,而尿皮质素对两者都具有高亲和力。我们研究了腹腔内(IP)注射CRF相关肽后结肠运动功能的变化。
在清醒大鼠体内记录结肠运动,这些大鼠的盲肠和近端结肠长期植入电极;或在体外记录远端结肠的运动;在未处理的大鼠中监测粪便排出量。
大鼠CRF、大鼠尿皮质素和两栖类蛙皮素(10微克/千克,腹腔注射)诱导了一种新的盲结肠肌电活动模式,其特征为持续时间长的成簇尖峰爆发;CRF注射后出现的百分比最高。腹腔注射肽(0.3-10微克/千克,腹腔注射)后增加粪便颗粒排出量的效力顺序为CRF>尿皮质素=蛙皮素。CRF-R1/R2拮抗剂阿斯特辛(33微克/千克,腹腔注射)和CRF-R1拮抗剂CP-154,526(20毫克/千克,皮下注射)抑制腹腔注射CRF诱导的盲结肠肌电活动变化以及腹腔注射CRF和水回避应激诱导的粪便排出。在体外,与注射生理盐水相比,注入肠系膜下动脉的CRF增加了远端结肠肌电活动。
这些结果表明,CRF在周围发挥作用以刺激结肠运动,并且CRF-R1主要参与介导腹腔注射CRF/尿皮质素和水回避应激诱导的结肠运动反应。